AKT1 and neoplasm: In one Type 2 case (Mouse 3), Pik3caH1047R, a hotspot mutation known to activate PI3K/Akt/mTORC1 signaling in human cancers29, was exclusively found in more advanced tumors, but not the relatively tumor-free SVZ (SVZL).